Literature DB >> 17617379

Lethal factor of anthrax toxin binds monomeric form of protective antigen.

Irina Chvyrkova1, Xuejun C Zhang, Simon Terzyan.   

Abstract

Anthrax toxin consists of three components: the enzymatic moieties edema factor (EF) and the lethal factor (LF) and the receptor-binding moiety protective antigen (PA). These toxin components are released from Bacillus anthracis as unassociated proteins and form complexes on the surface of host cells after proteolytic processing of PA into PA20 and PA63. The sequential order of PA heptamerization and ligand binding, as well as the exact mechanism of anthrax toxin entry into cells, are still unclear. In the present study, we provide direct evidence that PA63 monomers are sufficient for binding to the full length LF or its LF-N domain, though with lower affinity with the latter. Therefore, PA oligomerization is not a necessary condition for LF/PA complex formation. In addition, we demonstrated that the PA20 directly interacts with the LF-N domain. Our data points to an alternative process of self-assembly of anthrax toxin on the surface of host cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617379      PMCID: PMC1986636          DOI: 10.1016/j.bbrc.2007.06.124

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  A quantitative study of the interactions of Bacillus anthracis edema factor and lethal factor with activated protective antigen.

Authors:  J L Elliott; J Mogridge; R J Collier
Journal:  Biochemistry       Date:  2000-06-06       Impact factor: 3.162

2.  Mapping the anthrax protective antigen binding site on the lethal and edema factors.

Authors:  D Borden Lacy; Michael Mourez; Alexandre Fouassier; R John Collier
Journal:  J Biol Chem       Date:  2001-11-19       Impact factor: 5.157

3.  Crystal structure of the anthrax lethal factor.

Authors:  A D Pannifer; T Y Wong; R Schwarzenbacher; M Renatus; C Petosa; J Bienkowska; D B Lacy; R J Collier; S Park; S H Leppla; P Hanna; R C Liddington
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

4.  Stoichiometry of anthrax toxin complexes.

Authors:  Jeremy Mogridge; Kristina Cunningham; R John Collier
Journal:  Biochemistry       Date:  2002-01-22       Impact factor: 3.162

5.  The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.

Authors:  Jeremy Mogridge; Kristina Cunningham; D Borden Lacy; Michael Mourez; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

6.  Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen.

Authors:  Kristina Cunningham; D Borden Lacy; Jeremy Mogridge; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

7.  Interaction of the 20 kDa and 63 kDa fragments of anthrax protective antigen: kinetics and thermodynamics.

Authors:  Kenneth A Christensen; Bryan A Krantz; Roman A Melnyk; R John Collier
Journal:  Biochemistry       Date:  2005-01-25       Impact factor: 3.162

Review 8.  Anthrax toxin: receptor binding, internalization, pore formation, and translocation.

Authors:  John A T Young; R John Collier
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

9.  Structural determinants for the binding of anthrax lethal factor to oligomeric protective antigen.

Authors:  Roman A Melnyk; Krissi M Hewitt; D Borden Lacy; Henry C Lin; Chris R Gessner; Sheng Li; Virgil L Woods; R John Collier
Journal:  J Biol Chem       Date:  2005-11-17       Impact factor: 5.157

10.  A model of anthrax toxin lethal factor bound to protective antigen.

Authors:  D Borden Lacy; Henry C Lin; Roman A Melnyk; Ora Schueler-Furman; Laura Reither; Kristina Cunningham; David Baker; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-26       Impact factor: 11.205

View more
  4 in total

1.  Inhibition of anthrax lethal factor: lability of hydroxamate as a chelating group.

Authors:  Feng Li; Irina Chvyrkova; Simon Terzyan; Nancy Wakeham; Robert Turner; Arun K Ghosh; Xuejun C Zhang; Jordan Tang
Journal:  Appl Microbiol Biotechnol       Date:  2012-01-25       Impact factor: 4.813

2.  Association of Bacillus anthracis capsule with lethal toxin during experimental infection.

Authors:  J W Ezzell; T G Abshire; R Panchal; D Chabot; S Bavari; E K Leffel; B Purcell; A M Friedlander; W J Ribot
Journal:  Infect Immun       Date:  2008-12-08       Impact factor: 3.441

3.  Activity of the Bacillus anthracis 20 kDa protective antigen component.

Authors:  Rasha Hammamieh; Wilson J Ribot; Terry G Abshire; Marti Jett; John Ezzell
Journal:  BMC Infect Dis       Date:  2008-09-22       Impact factor: 3.090

4.  Serum-Mediated Cleavage of Bacillus anthracis Protective Antigen Is a Two-Step Process That Involves a Serum Carboxypeptidase.

Authors:  David L Goldman; Edward Nieves; Antonio Nakouzi; Johanna Rivera; Ei Ei Phyu; Than Htut Win; Jacqueline M Achkar; Arturo Casadevall
Journal:  mSphere       Date:  2018-06-27       Impact factor: 4.389

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.